Cytek Biosciences, Inc. (CTKB) fundamentals score
Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells (“Full Spectrum Profiling” or “FSP” technology).
Laboratory Analytical Instruments · Technology · Listed on NASDAQ
Overall: 4.6 out of 10, Weak long-term fundamentals
- Growth: 3.7/10
- Profitability: 2.1/10
- Financial health: 6.1/10
- Earnings quality: 8.2/10
- Valuation: 4.6/10
Scores are calculated from Cytek Biosciences, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Technology stocks
- Micron Technology, Inc. (MU): 9.0/10
- Broadcom Inc. (AVGO): 8.9/10
- Logitech International S.A. (LOGI): 8.8/10
- Applovin Corporation (APP): 8.7/10
- Cirrus Logic, Inc. (CRUS): 8.7/10
- Hamilton Beach Brands Holding Company (HBB): 8.7/10
- Nerdwallet, Inc. (NRDS): 8.7/10
- Sandisk Corporation (SNDK): 8.7/10